Novel Mammogram Measures Could Revolutionize Screening
By MedImaging International staff writers Posted on 06 Jan 2021 |
Image: New mammographic measures could help stratify breast cancer risk (Photo courtesy of Getty Images)
Two new mammogram-based measures of breast cancer (BC) risk are more effective in stratifying women than breast density and genetic risk factors, according to a new study.
Developed at the University of Melbourne (UNIMELB; Melbourne, Australia), Cancer Council Victoria (Melbourne, Australia), Monash University (Melbourne, Australia), and other institutions, the new mammogram‐based BC risk measures are based on image brightness (Cirrocumulus) and texture (Cirrus). Semi-automated measures of density are repeated under increasingly higher levels of brightness to create Cirrocumulus; artificial intelligence (AI) and high-speed computing resolve new aspects of the texture of a mammogram to create Cirrus.
When combined, the new measures show twice the risk gradient for the screen‐detected established measure of conventional mammographic density (Cumulus), as well as for younger‐diagnosis BC, and have at least the same discriminatory power as the current polygenic risk score. Cirrocumulus and Cirrus also show improved correlation with causal factors than conventional mammographic density, and could also help address the problem of dense breasts. The study was published on November 16, 2020, in the International Journal of Cancer.
“In terms of understanding how much women differ in their risks of breast cancer, these developments could be the most significant since the breast cancer genes BRCA1 and BRCA2 were discovered 25 years ago,” said senior author Professor John Hopper, MD, of UNIMELB. “As mammography is now digital, and our measures are now computerized, women could be assessed for their risk at the time of screening automatically and given recommendations for their future screening based on their personal risk, not just their age.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Melbourne
Cancer Council Victoria
Monash University
Developed at the University of Melbourne (UNIMELB; Melbourne, Australia), Cancer Council Victoria (Melbourne, Australia), Monash University (Melbourne, Australia), and other institutions, the new mammogram‐based BC risk measures are based on image brightness (Cirrocumulus) and texture (Cirrus). Semi-automated measures of density are repeated under increasingly higher levels of brightness to create Cirrocumulus; artificial intelligence (AI) and high-speed computing resolve new aspects of the texture of a mammogram to create Cirrus.
When combined, the new measures show twice the risk gradient for the screen‐detected established measure of conventional mammographic density (Cumulus), as well as for younger‐diagnosis BC, and have at least the same discriminatory power as the current polygenic risk score. Cirrocumulus and Cirrus also show improved correlation with causal factors than conventional mammographic density, and could also help address the problem of dense breasts. The study was published on November 16, 2020, in the International Journal of Cancer.
“In terms of understanding how much women differ in their risks of breast cancer, these developments could be the most significant since the breast cancer genes BRCA1 and BRCA2 were discovered 25 years ago,” said senior author Professor John Hopper, MD, of UNIMELB. “As mammography is now digital, and our measures are now computerized, women could be assessed for their risk at the time of screening automatically and given recommendations for their future screening based on their personal risk, not just their age.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Melbourne
Cancer Council Victoria
Monash University
Latest General/Advanced Imaging News
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging
- State-Of-The-Art System Enhances Accuracy of Image-Guided Diagnostic and Interventional Procedures
- Catheter-Based Device with New Cardiovascular Imaging Approach Offers Unprecedented View of Dangerous Plaques
- AI Model Draws Maps to Accurately Identify Tumors and Diseases in Medical Images